Simulations Plus Inc
NASDAQ:SLP
Simulations Plus Inc
Cost of Revenue
Simulations Plus Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Simulations Plus Inc
NASDAQ:SLP
|
Cost of Revenue
-$16.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-25%
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cost of Revenue
-$677.3m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-23%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cost of Revenue
-$101.5m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cost of Revenue
-$1.7B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cost of Revenue
-$53.5m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Cost of Revenue
-$66.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
See Also
What is Simulations Plus Inc's Cost of Revenue?
Cost of Revenue
-16.1m
USD
Based on the financial report for Feb 29, 2024, Simulations Plus Inc's Cost of Revenue amounts to -16.1m USD.
What is Simulations Plus Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-25%
Over the last year, the Cost of Revenue growth was -53%. The average annual Cost of Revenue growth rates for Simulations Plus Inc have been -15% over the past three years , -13% over the past five years , and -25% over the past ten years .